BIAF Stock: Dilution, SEC Filings & News

BIAF bioAffinity Technologies, Inc.

Price$2.26

Company About

As a biotechnology enterprise, bioAffinity Technologies, Inc. is dedicated to pioneering both non-invasive diagnostic solutions and precision therapeutics for cancer. Its portfolio features CyPath lung, a specialized diagnostic test designed for the early identification of lung cancer. Beyond diagnostics, the firm actively explores targeted therapies intended to combat cancer at a cellular level. This San Antonio, Texas-based company commenced operations in 2014.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Country

Exchange

NASDAQ Capital Market

Vol Avg.

3.72 M

Inst Own

0.000%

Float & OS

1.81 M / 1.82 M

Cash/Shr

$2.7

Market Cap & Ev

4.11 M / -3.26 M

Short Interest

3.7%

Borrow Rate

85.953%

Days to Cover

Overall Offering Risk

Warrant Exercise Risk

Research Report

Customize research

Recent Articles (8)

View All

bioAffinity Technologies Reports Third Quarter 2026 Results and Continued Momentum in CyPath® Lung Commercialization

Business Wire

Nov 6, 2026, 5:40 PM

bioAffinity Technologies Highlights Importance of Link Between Early Lung Cancer Detection and Curative Treatment During National Lung Cancer Awareness Month

Business Wire

Oct 29, 2026, 8:00 AM

bioAffinity Technologies to Present New Perspectives on CyPath® Lung’s Use for Cancer Risk Assessment at CHEST 2026

Business Wire

Oct 15, 2026, 8:00 AM

bioAffinity Technologies to Present Positive Research Data in Development of Its New Test Measuring Asthma and COPD-Related Lung Inflammation and Drug-Related Receptors at CHEST 2026

Business Wire

Oct 13, 2026, 8:00 AM

WallachBeth Capital Announces Closing of bioAffinity Technologies $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

PRNewswire

Oct 9, 2026, 12:30 PM

bioAffinity Technologies, Inc. Announces Closing of $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

Business Wire

Oct 9, 2026, 11:37 AM

WallachBeth Capital Announces bioAffinity Technologies Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

PRNewswire

Oct 8, 2026, 1:30 PM

bioAffinity Technologies, Inc. Announces Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

Business Wire

Oct 8, 2026, 12:07 PM

Recent Filings

View All

Type	Title	Date Released
8-K	bioAffinity Technologies Reports Third Quarter 2026 Results and Commercial Momentum for CyPath Lung	Nov 6, 2026, 5:28 PM
10-Q	Form 10-Q	Nov 6, 2026, 5:27 PM
424B5	November 2026 ATM \| Offering amount: $5,228,226 \| Bank: WallachBeth Capital LLC	Nov 3, 2026, 4:38 PM
424B5	AMENDED - November 2026 ATM \| Offering amount: $5,228,226 \| Bank: WallachBeth Capital LLC	Nov 2, 2026, 4:52 PM
8-K	bioAffinity Technologies to Highlight CyPath Lung Test at North Carolina Lung Cancer Awareness Event	Oct 29, 2026, 8:30 AM
DEF 14A	Form DEF 14A	Oct 23, 2026, 4:30 PM
8-K	bioAffinity Technologies to Present New Perspectives on CyPath® Lung at CHEST 2026	Oct 15, 2026, 9:30 AM
8-K	bioAffinity Technologies to Present Positive Research Data at CHEST 2026 for New Test Measuring Asthma and COPD-Related Lung Inflammation	Oct 13, 2026, 9:23 AM
PRER14A	Form PRER14A	Oct 13, 2026, 6:09 AM
8-K	bioAffinity Technologies Announces Approximately $4 Million Registered Direct Financing and Concurrent Private Placement	Oct 9, 2026, 4:30 PM
424B5	REGISTERED OFFERING	Oct 9, 2026, 12:00 PM
424B5	AMENDED - October 2026 ATM \| Bank: WallachBeth Capital LLC	Oct 9, 2026, 11:26 AM

Earnings

Apr

Q2 2027 Earnings reportUpcoming

Nov

Q4 2026 Earnings report

-3.94%beat

Aug

Q3 2026 Earnings report

-9.60%beat

May

Q2 2026 Earnings report

-0.81%beat

Mar

Q1 2026 Earnings report

-1.11%beat

Nov

Q4 2025 Earnings report

-4.74%missed

Related Healthcare stocks

All tickers

bioAffinity Technologies, Inc. BIAF

Related Healthcare stocks

Related Healthcare stocks